A Better Way to Conduct Clinical Research
The News Review:
- A Better Way to Conduct Clinical Research
- mniComm Systems Signs Licensing Deal with West Coast Clinical …
- Clinical research coordinator chef sell 2BD
- Research and Markets: Central and Eastern Europe: utsourcing …
- The Foundation for National Institutes of Health Announces …
- MSU to offer postgraduate course in Pharmacogenomics
A Better Way to Conduct Clinical Research
Drug Discovery & Development
Even seniors are adept at managing their bank accounts online and rarely step inside of banks. Having digital technology at our fingertips gives us instant access to information that once required thumbing through reams of paper and provides the ability to make quick work of laborious and menial tasks. The Past: Clinical research digitization slow to catch onClinical research a process that generates collects and analyzes large amounts of data lends itself naturally to the digitization process. However the adoption of information technology in clinical research has been glacially slow when compared to other industries and the mass adoption of the Internet. Why has it taken so long? I agree with my colleague Dr. Joseph DeVeaugh-Geiss a former international director of central nervous system clinical research at GlaxoSmithKline who feels that part of the reason for slow adoption is mindset. “You have to get through to the generations that you can make a transaction without touching a piece of paper” he said.
mniComm Systems Signs Licensing Deal with West Coast Clinical …
PR Newswire (press release) (press release)
(TCBulletinBoard: MCM) a leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that it has entered into a licensing agreement with a west coast Clinical Research rganization (CR) for the use of their TrialMaster(TM) solution in a Technology Transfer model. The agreement is expected to generate more than $1. 1 million from licensing maintenance hosting and consulting fees for mniComm over the next three years. It also allows this leading CR to expand its offering to its customers to include the latest in cutting edge technologies for electronic data capture. “We are extremely pleased to have been selected by this new client and we believe that our unique platform of eClinical solutions is being recognized within the clinical research community as a valuable and important tool for facilitating the development of life-saving drugs and devices” said Stephen Johnson mniComm’s C.
Clinical research coordinator chef sell 2BD
Blockshopper
She has been the National Lung Screening Trial Coordinator at Georgetown University’s Lombardi Comprehensive Cancer Center. Prior to that she was a clinical research assistant at the university.
Research and Markets: Central and Eastern Europe: utsourcing …
Business Wire (press release) (press release)
researchandmarkets. The number of clinical trials initiated in Central and Eastern Europe more than tripled from 2002 to 2007 making the region a key part of global clinical research. This comprehensive analysis focuses on the evolution of the clinical trials industry in the CEE region and the outsourcing strategies that CRs and emerging pharmaceutical and biotech companies need to operate there. Topics include: Market information on 25+ countries including: Bulgaria Czech Republic Hungary Poland Romania Russia Turkey and Ukraine EU directives and other European regulatory trends Exclusive interviews with executives from the top CRs Factors driving growth Companies acquiring local CRs and why Current drug development pipeline riginal and proprietary charts and graphs Central and Eastern Europe is recommended for: Biotech and pharmaceutical companies seeking information on growth and challenges in the Central and Eastern Europe market Investment firms covering the life sciences industry in emerging markets CRs conducting business in Central and Eastern European countries Don’t miss out on this important resource detailing the growing clinical trials industry in Central and Eastern Europe! For more information visit.
The Foundation for National Institutes of Health Announces …
PR Newswire (press release) (press release)
chairman of the Foundation for NIH. “We are grateful to sanofi-aventis for advancing NIH-sponsored clinical research with this generous donation and hope that other pharmaceutical companies will follow its lead. ” “We are proud to support the ability of the NIH to pursue new and cutting-edge research by freeing up much needed resources” said Marc Cluzel M. Senior Vice President Research & Development at sanofi-aventis. “We have been committed to supporting clinical research in key therapeutic areas for more than 50 years and this partnership is another example of the company’s steadfast commitment to advancing research and ultimately helping patients.
Related from Vguideu: We Need More Renaissance Scientists
MSU to offer postgraduate course in Pharmacogenomics
Indian Express
init(”tabnavhc2″ 0) M S UNIVERSITY (MSU) has decided to introduce a post-graduate degree course in Pharmacogenomics from the next academic year. Pharmacogenomics is a new branch of pharmacology that studies the influence of genetic variation on drug response on patients. MSU has received the seed money from the Centre under the 11th Five-Year Plan to start the course in Pharmacogenomics and Clinical Research. MSU ViceChancellor Prof Ramesh Goyal told Newsline : “MSU has mooted proposals to start courses in Pharmacogenomics and clinical research under the 11th Five Year Plan. These courses will be open pharmacy students as well as graduates in pure science. There is an Indian Council for Medical Research (ICMR) centre in Pondicherry that is doing research in the field of Pharmacogenomics. “He added: “But there are not many centres and institutes in the country that offer courses in Pharmacogenomics.
Written by admin on August 6th, 2009 with
no comments.
Read more articles on News.